|
Volumn 6, Issue 3, 2006, Pages 41-43
|
Acting out of ethics: What the open letter asks
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD SUBSTITUTE;
HEMOGLOBIN;
POLYMERIZED HEMOGLOBIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG INDUSTRY;
EMERGENCY HEALTH SERVICE;
EMERGENCY TREATMENT;
ETHICS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INTERPERSONAL COMMUNICATION;
LEGAL LIABILITY;
PROFESSIONAL STANDARD;
PUBLIC RELATIONS;
RANDOMIZED CONTROLLED TRIAL;
RESEARCH ETHICS;
SCIENTIFIC MISCONDUCT;
SHORT SURVEY;
UNITED STATES;
BLOOD SUBSTITUTES;
COMMUNITY-INSTITUTIONAL RELATIONS;
DISCLOSURE;
DRUG INDUSTRY;
EMERGENCY SERVICE, HOSPITAL;
EMERGENCY TREATMENT;
ETHICS COMMITTEES, RESEARCH;
ETHICS, RESEARCH;
HEMOGLOBINS;
HUMANS;
LIABILITY, LEGAL;
RANDOMIZED CONTROLLED TRIALS;
SCIENTIFIC MISCONDUCT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 33745103651
PISSN: 15265161
EISSN: 15360075
Source Type: Journal
DOI: 10.1080/15265160600685937 Document Type: Short Survey |
Times cited : (2)
|
References (7)
|